Added to YB: 2026-07-15
Pitch date: 2026-07-12
NVO [neutral]
Novo Nordisk A/S
-0.2%
current return
Author Info
Quality Stocks helps you find valuable insights to become a better investor, discover quality companies, and find investment ideas. Sign up for the newsletter.
Company Info
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products.
Market Cap
DKK 1.4T
Pitch Price
DKK 49.17
Price Target
N/A
Dividend
3.61%
EV/EBITDA
8.89
P/E
11.83
EV/Sales
4.76
Sector
Pharmaceuticals
Category
growth
My 12 Picks for 2026, Q1 Performance Review - Novo Nordisk A/S
NVO (update): New CEO deliberately sacrificing near-term margins & growth to build long-term GLP-1 dominance—aggressively expanding production capacity & lowering pricing to secure large supply contracts, locking out competitors & cementing multi-decade footprint. Strong Q1 rebound.
Read full article (1 min)